Schizophrenia: a multisystem disease? (Q24633845)

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951587

Weight gain in antipsychotic-naive patients: a review and meta-analysis

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951587

Metabolic profile of antipsychotic-naive individuals with non-affective psychosis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951587

Schizophrenia: from the brain to peripheral markers. A consensus paper of the WFSBP task force on biological markers

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951587

Metabolic syndrome in people with schizophrenia: a review.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951587

First- v. second-generation antipsychotics and risk for diabetes in schizophrenia: systematic review and meta-analysis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951587

Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951587

Prevalence of diabetes, metabolic syndrome and metabolic abnormalities in schizophrenia over the course of the illness: a cross-sectional study

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951587

Antipsychotic drugs and diabetes--an application of the Austin Bradford Hill criteria.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951587

Physical health and schizophrenia

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951587

Schizophrenia, neuroleptic medication and mortality

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951587

Schizophrenia and increased risks of cardiovascular disease

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951587

Atypical antipsychotic drug use and diabetes

27 September 2017

1 reference

https://api.crossref.org/works/10.1177%2F1359786810382059

Metabolic risk factors among medicaid outpatients with schizophrenia receiving second-generation antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786810382059

Prevalence of cardiovascular risk factors and disease in people with schizophrenia: a population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786810382059

Insulin resistance and adiponectin levels in drug-free patients with schizophrenia: A preliminary report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786810382059

Higher white blood cell counts are associated with an increased risk for metabolic syndrome and more severe psychopathology in non-diabetic patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786810382059

Assessment of antipsychotic-related risk of diabetes mellitus in a Medicaid psychosis population: sensitivity to study design

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786810382059

Mortality among patients with schizophrenia and reduced psychiatric hospital care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786810382059

Impact of obesity on health-related quality of life in schizophrenia and bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786810382059

The Clinical Antipsychotic Trials Of Intervention Effectiveness (CATIE) Schizophrenia Trial: clinical comparison of subgroups with and without the metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786810382059

Insulin sensitivity, adjusted beta-cell function and adiponectinaemia among lean drug-naive schizophrenic patients treated with atypical antipsychotic drugs: a nine-month prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786810382059

Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786810382059

Metabolic syndrome in first episode schizophrenia - a randomized double-blind controlled, short-term prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786810382059

Metabolic risk factors in drug-naive patients with first-episode psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786810382059

Elevated expression of integrin alpha(IIb) beta(IIIa) in drug-naïve, first-episode schizophrenic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786810382059

Effects of antipsychotics on fat deposition and changes in leptin and insulin levels. Magnetic resonance imaging study of previously untreated people with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786810382059

A 4-fold risk of metabolic syndrome in patients with schizophrenia: the Northern Finland 1966 Birth Cohort study

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951587

Increase in HLA-DR immunoreactive microglia in frontal and temporal cortex of chronic schizophrenics

28 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20923915

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Accumulation of macrophages in the CSF of schizophrenic patients during acute psychotic episodes

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20923915

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Impaired glucose tolerance in first-episode drug-naïve patients with schizophrenia

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20923915